Antibiotics for spontaneous bacterial peritonitis in cirrhotics
- 23 July 2001
- reference entry
- Published by Wiley
- No. 3,p. CD002232
- https://doi.org/10.1002/14651858.cd002232
Abstract
Spontaneous bacterial peritonitis is mainly a complication of cirrhotic ascites that occurs in the absence of any intra‐abdominal, surgically treatable source of infection. Antibiotics have been recommended as the mainstay treatment for spontaneous bacterial peritonitis. However, this recommendation is not based on convincing evidence. It has been proposed that treatment should cover Gram‐negative enteric bacteria and Gram‐positive cocci, that are responsible for up to 90% of cases. To evaluate the effectiveness and safety of different types and ways of antibiotic therapy for spontaneous bacterial peritonitis in cirrhotic patients. Electronic searches on the Cochrane Hepato‐Biliary Group Trials Register (March 2000), the Cochrane Controlled Trials Register (Cochrane Library Issue 3, 2000), MEDLINE (1966‐2000), EMBASE (1980‐2000); scanning the references of all identified studies; contacting the first author of each included trial. Randomised trials comparing different types of antibiotics for spontaneous bacterial peritonitis in cirrhotic patients. Data were independently extracted by two reviewers. Relative risks or weighted mean differences, with their 95% confidence intervals were estimated using 'intention‐to‐treat' analyses. Nine trials dealing with 684 patients diagnosed with spontaneous bacterial peritonitis were included. No placebo‐controlled trial was found. Each of the included trials compared different antibiotics, and no meta‐analysis could be performed. We were unable to establish the optimal dose or duration of antibiotic therapy and found no convincing evidence that cefotaxime is more effective than ampicillin‐tobramycin or that oral quinolones should be recommended for patients with less severe manifestations of the disease. This review provides no clear evidence for the treatment of cirrhotic patients with spontaneous bacterial peritonitis. Until large, well‐conducted, trials provide adequate evidence, treatment must be based on clinical experience.Keywords
This publication has 22 references indexed in Scilit:
- Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized studyJournal of Hepatology, 2000
- Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patientsJournal of Hepatology, 2000
- A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patientsHepatology, 1997
- Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitisGastroenterology, 1996
- Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter studyHepatology, 1995
- Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patientsAntimicrobial Agents and Chemotherapy, 1993
- Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patientsHepatology, 1991
- Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitisGastroenterology, 1991
- Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis†Hepatology, 1989
- Cefotaxime Is More Effective Than Is Ampicillin–Tobramycin in Cirrhotics With Severe InfectionsHepatology, 1985